BioAge Labs (BIOA) Current Deferred Revenue (2023 - 2026)
BioAge Labs (BIOA) posted Current Deferred Revenue of $6.2 million for Q1 2026, up 7.59% sequentially from $5.8 million in Q4 2025, and down 24.34% YoY from $8.2 million in Q1 2025.
BioAge Labs (BIOA) Current Deferred Revenue (2023 - 2026) Analysis & Trends
BioAge Labs has reported Current Deferred Revenue for 4 years, with the latest figure at $6.2 million in Q1 2026.
- Quarterly Current Deferred Revenue fell 24.34% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (down 24.34% YoY) and the FY2025 annual result came in at $5.8 million, down 26.48% from the prior year.
- Current Deferred Revenue rose to $6.2 million in Q1 2026 per BIOA's latest filing, from $5.8 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $8.2 million in Q1 2025 and troughed at $3.3 million in Q4 2023.
- A 4-year average of $6.6 million and a median of $7.5 million in 2025 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue jumped 136.22% in 2024, then dropped 26.48% in 2025.
- Over 4 years, Current Deferred Revenue stood at $3.3 million in 2023, then soared by 136.22% to $7.8 million in 2024, then decreased by 26.48% to $5.8 million in 2025, then grew by 7.59% to $6.2 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $6.2 million, $5.8 million, and $7.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | BioAge Labs | 436.28 Mn | 436.28 Mn | -14.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.36 Mn |
| Mar 31, 2026 | 6.19 Mn |
| Dec 31, 2025 | 5.75 Mn |
| Sep 30, 2025 | 7.51 Mn |
| Jun 30, 2025 | 7.70 Mn |
| Mar 31, 2025 | 8.18 Mn |
| Dec 31, 2024 | 7.83 Mn |
| Dec 31, 2023 | 3.31 Mn |